Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Making it Simple
N
Nice Insight
Apr 12, 2017
PTV-M11-16-AP-030
Formulation
PA TV (video)
Ken Seufert, Managing Director, Meggle USA
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
Related Content
High-Concentration
High-Concentration Biologics Are Redefining Subcutaneous Delivery
Pharma's Almanac
PAO-07-26-PA-08
Jul 15, 2026
LAI Formulation
The Formulation Science Behind Extended Drug Release
Pharma's Almanac
PAO-07-26-PA-03
Jul 9, 2026
Drug–Device
Designing Formulations Around Devices Rather Than Vice Versa
Pharma's Almanac
PAO-07-26-PA-04
Jul 7, 2026
Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03
Jun 30, 2026
Partnership
The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation
The Solubility Company
PR-05-26-02
May 13, 2026
Oral mAbs
Oral Delivery of Monoclonal Antibodies: The Pursuit Continues
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-04-26-PA-05
Apr 7, 2026
Neuro CMC
Producing Therapies for the Brain: Manufacturing and Formulation Challenges for CNS Biologics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-03
Apr 3, 2026
Formulation
Quotient Sciences and Intrepid Labs form Strategic Partnership to Accelerate AI-guided Formulation Development
Quotient Sciences
PR-04-26-05
Apr 1, 2026
Long-Acting Delivery
Long-Acting Drug Delivery for Chronic Metabolic and Renal Conditions
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-26-PA-13
Mar 23, 2026
Autoinjectors
Why Autoinjectors Fail After Phase III — and Why It’s Not a Device Problem
David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-26-NI-14
Jan 14, 2026
Digital Formulation
Digital and In Silico Transformation in Biologics Formulation
Tim Menzen, Ph.D.; Andrea Arsiccio, Ph.D.,
Coriolis Pharma
PAO-12-25-CL-02
Dec 9, 2025
LNPs
Expanding LNP Applications Beyond mRNA Vaccines
Jan Bekker; Phillip Elliott, Ph.D.; Jason Arcediano
BioCina
PAO-10-25-CL-07
Nov 17, 2025
Previous slide
Next slide
